Very early researchEnded earlyNCT04630353
What this trial is testing
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
Who this might be right for
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
AstraZeneca 10